HR outsourcing provider Insperity (NYSE:NSP) met Wall Street’s revenue expectations in Q1 CY2025, with sales up 3.4% year on year to $1.86 billion. Its non-GAAP profit of $1.56 per share was 23% below analysts’ consensus estimates.
Is now the time to buy NSP? Find out in our full research report (it’s free).
Insperity (NSP) Q1 CY2025 Highlights:
- Revenue: $1.86 billion vs analyst estimates of $1.87 billion (3.4% year-on-year growth, in line)
- Adjusted EPS: $1.56 vs analyst expectations of $2.02 (23% miss)
- Adjusted EBITDA: $102 million vs analyst estimates of $127.8 million (5.5% margin, 20.2% miss)
- Management lowered its full-year Adjusted EPS guidance to $2.76 at the midpoint, a 21.8% decrease
- EBITDA guidance for the full year is $217.5 million at the midpoint, below analyst estimates of $259.4 million
- Operating Margin: 3.7%, down from 6% in the same quarter last year
- Free Cash Flow was -$449 million, down from $26 million in the same quarter last year
- Market Capitalization: $2.6 billion
StockStory’s Take
Insperity’s first quarter results reflected a combination of modest year-over-year revenue growth and a sharp increase in benefits costs, which management attributed to a rise in large medical claims and accelerated payments across both current and prior periods. CEO Paul Sarvadi described a "sudden reversal of optimism" among small and mid-sized business clients, linked to recent government policy initiatives and tariffs, which led to delayed or canceled client onboarding late in the quarter.
Looking ahead, management lowered full-year profit guidance and flagged that elevated healthcare claims are likely to persist, though they have begun targeted pricing actions and are evaluating benefit plan design changes for 2026. Insperity also highlighted progress on its Workday strategic partnership, viewing it as a significant long-term growth driver. CFO Jim Allison emphasized that current challenges are being factored into conservative forecasts in order to position the company for improved profitability next year.
Key Insights from Management’s Remarks
Insperity’s management spent considerable time on the call detailing the operational and market factors that shaped the quarter’s underperformance versus expectations, particularly the impact of higher healthcare benefit costs and shifts in client sentiment.
- Benefits Cost Acceleration: Management reported an 8.4% year-over-year increase in benefits cost per covered employee, driven by a spike in large medical claims and accelerated claim payments. CFO Jim Allison noted this dynamic was "unprecedented" in its breadth across current and prior claim periods.
- Client Sentiment Shift: CEO Paul Sarvadi cited a “dramatic change in sentiment” among the company’s small and mid-sized business customers, attributed to tariffs and economic policy changes. This shift led to both delayed and canceled client onboarding, impacting worksite employee growth.
- Retention Remains High: Despite market turbulence, client retention reached 91% for the quarter, which Sarvadi described as at the "high end of our historical range." This was supported by ongoing investments in sales and service realignment.
- Pricing and Plan Design Adjustments: To address higher benefits costs, Insperity has already begun selective pricing increases for certain accounts and is considering plan design changes for 2026. The company believes these actions will realign pricing with costs by next year.
- Workday Partnership Progress: The company launched its internal Workday platform in March and finalized a go-to-market plan for a joint client solution with Workday. Management expects this partnership to expand Insperity’s reach into the mid-market segment and potentially double its mid-market business over time.
Drivers of Future Performance
Management expects continued headwinds from elevated healthcare costs and uncertain small business sentiment to weigh on profitability through the remainder of the year, while strategic initiatives—including pricing actions and the Workday partnership—are positioned as key levers for future growth and margin improvement.
- Benefits Cost Management: The company is implementing targeted pricing increases and evaluating benefit plan changes, aiming to mitigate higher healthcare claim trends and restore gross profit margins by 2026.
- Workday Joint Solution Launch: Insperity believes its joint offering with Workday, expected to be available in 2026, could drive meaningful mid-market client growth and enhance retention, providing a new source of revenue and margin expansion.
- Economic Policy Uncertainty: Management highlighted ongoing uncertainty in the macroeconomic environment, especially among small and mid-sized businesses, as a risk to client hiring and onboarding momentum for the rest of the year.
Top Analyst Questions
- Andrew Nicholas (William Blair): Asked about the duration and quantification of client onboarding pauses. Management explained the "shock factor" from recent policy changes but observed some moderation as clients resumed decision-making.
- Andrew Nicholas (William Blair): Inquired about the cadence and future trajectory of Workday partnership costs. CFO Jim Allison said costs will remain steady in 2025 but should decline after product launch, with some expenses capitalizable over time.
- Tobey Sommer (Truist): Questioned what macro policy changes could restore client confidence. CEO Paul Sarvadi suggested regulatory clarity and stable tax policy could quickly improve small business sentiment.
- Mark Marcon (Baird): Sought clarity on the timing and client receptivity to pricing adjustments due to higher healthcare costs. Management indicated most pricing changes would be phased in during client renewals throughout the year, with full alignment expected by early 2026.
- Jeff Martin (ROTH Capital Partners): Probed the profitability potential of the Workday joint solution. Management expects the offering to command higher upfront and ongoing pricing, projecting it as a future margin contributor though specifics are still being assessed.
Catalysts in Upcoming Quarters
In the coming quarters, the StockStory team will be monitoring (1) whether Insperity’s targeted pricing actions and benefit plan adjustments start to moderate healthcare cost pressures, (2) signs of stabilization or renewed growth in worksite employee onboarding as small business sentiment evolves, and (3) measurable progress in the rollout and early adoption of the Workday joint client solution. Execution on these fronts will be central to tracking the company’s path toward margin recovery and long-term growth.
Insperity currently trades at a forward P/E ratio of 18.7×. Should you load up, cash out, or stay put? The answer lies in our free research report.
The Best Stocks for High-Quality Investors
The market surged in 2024 and reached record highs after Donald Trump’s presidential victory in November, but questions about new economic policies are adding much uncertainty for 2025.
While the crowd speculates what might happen next, we’re homing in on the companies that can succeed regardless of the political or macroeconomic environment. Put yourself in the driver’s seat and build a durable portfolio by checking out our Top 5 Growth Stocks for this month. This is a curated list of our High Quality stocks that have generated a market-beating return of 176% over the last five years.
Stocks that made our list in 2020 include now familiar names such as Nvidia (+1,545% between March 2020 and March 2025) as well as under-the-radar businesses like the once-small-cap company Comfort Systems (+782% five-year return). Find your next big winner with StockStory today.